BioTuesdays

Tag - hepatitis C

Aethlon readies U.S. study of the Hemopurifier

By Len Zehr Aethlon Medical (OTCQB:AEMD), sporting FDA approval of an investigational drug exemption (IDE), plans to begin treating patients infected with hepatitis C virus (HCV) early next year in a feasibility study...